Previous Article | Next Article 
Journal of Clinical Microbiology, November 2002, p. 3938-3941, Vol. 40, No. 11
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.11.3938-3941.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
"Actinobaculum massiliae," a New Species Causing Chronic Urinary Tract Infection
Gilbert Greub and Didier Raoult*
Unité des Rickettsies, Faculté de Médecine, Université de la Méditerranée, Marseille, France
Received 28 March 2002/
Returned for modification 16 July 2002/
Accepted 12 August 2002

ABSTRACT
We report on a new
Actinobaculum species, "
Actinobaculum massiliae,"
isolated from the urine of an elderly woman with recurrent cystitis.
Its phenotypic pattern was similar to those of both of the other
Actinobaculum species described to date. On 16S rRNA sequencing,
the Marseille isolate shared 95% homology with
Actinobaculum suis, 92 to 93% homology with
Actinobaculum schaalii, 91 to
92% homology with
Arcanobacterium spp., and 87 to 90% homology
with
Actinomyces species. A bootstrap value of 99% supports
the node separating the
Actinobaculum sp. from its closest neighbor
(
A. suis). In conclusion, on the basis of phenotypic, genotypic,
and phylogenetic assessments, we show that the Marseille isolate
is a previously unrecognized organism within the
Actinobaculum genus, and we propose placement of the organism in the taxon
"
Actinobaculum massiliae."

INTRODUCTION
Actinobaculum suis, initially described as
Eubacterium suis (
7), was reclassified as
Actinomyces suis in 1992 (
4). Its taxonomy
was further modified in 1997 by Lawson et al. (
3), who proposed
a new genus,
Actinobaculum, that includes two species:
Actinobaculum schaalii and
A. suis.
A. suis is pathogenic for sows, leading
to cystitis (
6) and abortion (
9). The type strain of
A. schaalii was isolated from the blood of a 64-year-old man with chronic
pyelonephritis (
3), suggesting that it may be an agent of urinary
tract infection. Here we report on a new
Actinobaculum species
that we named "
Actinobaculum massiliae." The organism was isolated
from the urine of an elderly woman with recurrent cystitis.

CASE REPORT
An 81-year-old woman presented with brachiofacial ischemic stroke
in the summer of 1999, and a bladder catheter was placed. The
catheter was associated with cystitis and was removed 1 month
later. A gram-positive bacillus was the only bacterium isolated
from her urine at that time. This bacterium, recovered by a
private laboratory and thought to be a vaginal contaminant,
was not identified, nor was it tested for its antibiotic susceptibility.
Empirical therapy with amoxicillin-clavulanate was given for
2 weeks, with partial and temporary resolution of the symptoms.
Repeated episodes of pollakiuria with urge urinary incontinence
were reported starting in March 2000. In May 2001, a urine culture
was done when symptoms of cystitis, i.e., dysuria and pollakiuria,
reappeared. At that time, a gram-positive bacillus was again
isolated from the patient's urine, but this time it was identified
as an
Actinobaculum sp. by 16S rRNA amplification and sequencing.
It was found to be susceptible to all antibiotics used for the
treatment of lower urinary tract infection. Despite successive
therapy with amoxicillin and trimethoprim-sulfamethoxazole,
in October 2001 the same organism was recovered from the patient's
urine at a high concentration (10
6 bacteria/ml), and it was
then resistant to trimethoprim-sulfamethoxazole. Rifampin therapy
(900 mg/day) initiated in October 2001 failed, and it was later
associated with in vitro resistance to rifampin (December 2001)
and persistence of the pollakiuria. Cure was finally achieved
with doxycycline.

MATERIALS AND METHODS
The strain isolated on sheep blood agar from the patient's urine
in May 2001 was used for phenotypic, genotypic, and phylogenetic
analyses. Growth requirements and colony morphology were studied
with cultures set up on Columbia sheep blood agar (BioMérieux,
Marcy l'Etoile, France) and chocolate agar (BioMérieux)
and incubated at 37°C in a 5% CO
2 atmosphere. In addition,
we tested for the presence of growth under anaerobic conditions
on sheep blood agar at 37°C (GENbag anaer; BioMérieux),
and anaerobic conditions were confirmed by using the AnaerIndicator
strip (Merck, Darmstadt, Germany). A mobility test was performed
by the hanging-drop method. Oxidase and catalase activities
were evaluated by routine procedures. Additional biochemical
tests were performed by inoculation of the API 20Strep (BioMérieux)
and API Coryne (BioMérieux) systems according to the
instructions of the manufacturer, with the exception that the
incubation time was increased to 72 h. The cell wall fatty acid
composition was analyzed by gas chromatography (
5).
DNA was extracted with the FastDNA kit (Bio 101, Carlsbad, Calif.) and a FastPrep120 grinder (Bio 101) according to the instructions of the manufacturer. PCR amplification of the 16S RNA gene was performed with primers fD1 and rP2 (8) and Taq DNA polymerase (Gibco BRL, Life Technologies), also as specified by the manufacturer. The success of the amplification was determined by electrophoresis of the PCR products in a 1% agarose gel and staining with ethidium bromide. The PCR products were purified by use of the QIAquick PCR purification kit (Qiagen, Courtaboeuf, France). Sequencing was performed by using the dRhodamine Terminator Cycle Sequencing Ready Reaction kit with one of nine different primers and AmpliTaq DNA (Perkin-Elmer Biosystems, Warrington, England) with a 3100 ABI Prism automated sequencer (Applied Biosystems, Courtaboeuf, France). Sequences derived from each primer were aligned, compared, and combined into a single 16S rRNA sequence by using Autoassembler software (version 2.1; Applied Biosystems). The validity of the sequence obtained was assessed by comparison with two additional sequences similarly obtained, but from two other PCRs of the same template DNA. The sequence was compared with all eubacterial 16S rRNA sequences available in the GenBank database by using the BLASTN 2.2.2 program available on the National Center for Biotechnology Information website (www.ncbi.nlm.nih.gov) (1). The 16S rRNA sequence of the Marseille isolate was aligned with those of other members of the family Actinomycetaceae, and the degree of 16S rRNA homology was determined by using the CLUSTWAL W program supported by the DDBJ website (www.ddbj.nig.ac.jp). Sequences were edited by removal of the longer 5' and 3' ends so that their lengths matched that of the shortest sequence. The edited sequences were then analyzed by the distance matrix program (Kimura's correction) supported by the DDBJ website. With these sequences, additional trees were constructed by using the distance matrix, parsimony, and maximum likelihood programs of the Phylip package (2). The isolates recovered in October and December were identified by 16S rRNA amplification and sequencing of a segment of about 500 bp with the following primers: 5'-CAGCAGCCGCGGTAATAC-3' and 5'-CACGAGCTGACGACA-3'.
Nucleotide sequence accession number.
The 16S rRNA gene sequence of the Marseille "A. massiliae" isolate has been deposited in the GenBank database under accession number AF487679.

RESULTS
Primary isolation was obtained by inoculation of sheep blood
agar (BioMérieux) with 10 µl of midstream urine
and incubation at 37°C in a 5% CO
2 atmosphere for 72 h.
No growth was observed when urine was inoculated on bromocresol
purple lactose agar (Becton Dickinson, Meylan, France). Nonhemolytic
small greyish colonies could be seen on blood agar; the strain
presented two colony types after 5 days of incubation. Microscopic
examination showed nonmotile, non-acid-fast, non-spore-forming,
gram-positive organisms. Some bacteria were poorly stained with
the Gram stain, and a few exhibited branching. Growth was observed,
although it was slower, under anaerobic conditions and on chocolate
agar. Green hemolysis was observed with culture on chocolate
agar. Bacteria grown on the latter medium were tested for catalase
reactivity, which was absent. Acid was produced from glucose,
maltose, ribose, xylose, and trehalose, but not from mannose,
mannitol, sorbitol, or amidon. Slight acid production from raffinose
was observed. Esculin and gelatin were not hydrolyzed. Nitrate
was not reduced to nitrite. Hippurate was hydrolyzed. Pyrazinamidase
and

-glucosidase activities were detected. Inversely, no pyrrolidonyl
arylamidase, alkaline phosphatase,

-galactosidase, ß-glucuronidase,
ß-galactosidase,
N-acetyl-ß-glucosaminidase,
urease, leucine arylamidase, or arginine dihydrolase activity
was detected (Table
1). The whole-cell fatty acid composition
of the Marseille isolate demonstrated relatively large amounts
of hexadecanoic acid (C
16:0; 41.5%),
cis-octadec-9-enoic-acid
(C
18:1
9c; 24.2%), and octadecanoic acid (C
18:0; 8.7%). The Marseille
isolate shared 95% homology with
A. suis, 93% homology with
A. schaalii, 91 to 92% homology with
Arcanobacterium spp., and
87 to 90% homology with
Actinomyces species (Table
2). The shortest
16S rRNA sequence included in the phylogenetic analysis was
that of
Actinomyces turicensis (1310 bp); accordingly, alignment
began at base 1 of the 16S rRNA gene of
A. turicensis. The Marseille
isolate clustered with the
Actinobaculum spp. by phylogenetic
analysis (matrix distance approach) of the 16S rRNA genes of
species of the family
Actinomycetaceae (Fig.
1). Thus, a bootstrap
value of 97% in the neighbor-joining tree supported the fork
separating the
Actinobaculum spp. (including the Marseille isolate)
from their closest relatives: members of the genus
Arcanobacterium.
More importantly, the isolate was clearly different from its
closest neighbor (
A. suis), with a bootstrap value of 99% (Fig.
1). Parsimony and maximum likelihood methods confirmed that
the Marseille isolate clustered within the
Actinobaculum spp.
and that its lineage was clearly different from that of
A. suis.
The isolates recovered in October and December 2001 shared 100%
sequence homology with the type strain, recovered in May 2001
from urine specimens from the same patient.
View this table:
[in this window]
[in a new window]
|
TABLE 1. Comparison of the "A. massiliae" phenotype with those of other members of the family Actinomycetaceae, showing its relatedness to other Actinobaculum spp.a
|
View this table:
[in this window]
[in a new window]
|
TABLE 2. Comparison of 16S rRNA sequence homology of "A. massiliae" with those of other members of the family Actinomycetaceae and Corynebacterium amycolatum
|

DISCUSSION
In this paper, we described a new species, "
A. massiliae," recovered
from the urine of an 81-year-old woman with a chronic urinary
tract infection. The same strain was recovered three times over
a 7-month period, highlighting the persistence of the infection
despite antibiotic treatment. Interestingly, this strain was
not recovered from bromocresol purple lactose agar (Becton Dickinson),
which is the medium routinely used in the Marseille laboratory,
even after prolonged incubation. Our use of sheep blood agar
and prolonged incubation, which permitted strain recovery, was
motivated by the presence of 10
6 leukocytes/ml in the patient's
urine. This is the second report of a human infection due to
Actinobaculum species: the
A. schaalii type strain was isolated
from a 64-year-old man with chronic pyelonephritis (
3). Of interest,
A. suis has been isolated from sows with cystitis (
6). It should
be stressed that chronic urinary tract infection due to
Actinobaculum species might be underdiagnosed because these organisms cannot
be isolated by routine procedures. In addition, the phenotypic
heterogeneity of the colonies after 5 days of incubation may
lead to an erroneous interpretation of sample contamination
with two different species of gram-positive bacilli. The infection
described in the present study was cured only with doxycycline,
which may be the treatment of choice for such infections. As
recurrence occurred after therapy with amoxicillin and trimethoprim-sulfamethoxazole
and as resistance to rifampin was observed after exposure to
that drug, close follow-up with stringently controlled urine
cultures seems mandatory to confirm a cure.
The phenotypic and biochemical patterns suggested that the Marseille isolate was related to A. schaalii. Indeed, tests for urease and ß-galactosidase activities were found to be negative, and acid was produced from glucose, maltose, ribose, and xylose. However, as for A. suis, acid was produced from glycogen. In addition, the Marseille isolate showed only 95% 16S rRNA sequence homology with A. suis and showed even lower degrees of homology with all other known species of the family Actinomycetaceae. Our phylogenetic analysis demonstrated that the Marseille isolate shares some degree of evolutionary descent with members of the genus Actinobaculum. In conclusion, on the basis of phenotypic, genotypic, and phylogenetic assessments, we show that the Marseille isolate is a previously unrecognized organism within the genus Actinobaculum, and we propose placement of the organism in the taxon "Actinobaculum massiliae."
Description of "A. massiliae" sp. nov.
Massilia is the old Greek and Roman name for Marseille, where the organism was isolated. The organism consists of straight to slightly curved rods, some of which exhibit branching. It has nonmotile, non-acid-fast, gram-positive (easily decolorized) cells. Colonies on sheep blood agar are 1 mm in diameter after 72 h of incubation at 37°C in a 5% CO2 atmosphere, and there is no hemolysis. It is facultatively aerobic. Esculin and gelatin were not hydrolyzed. Nitrate was not reduced to nitrite. Acid was produced from glucose, maltose, ribose, glycogen, and xylose. The type strain of "A. massiliae," which was isolated from the urine of an 81-year-old woman with cystitis, has been deposited in the Collection de l'Institut Pasteur, Paris, France, as strain CIP 107404T.

ACKNOWLEDGMENTS
We thank Christiane Bibard and Veronique Brice for help.

FOOTNOTES
* Corresponding author. Mailing address: Unité des Rickettsies, CNRS UPRESA 6020, Faculté de Médecine, Université de la Méditerranée, 27, Boulevard Jean Moulin, 13385 Marseille Cedex 05, France. Phone: (00) 33.491.32.43.75. Fax: (00) 33.491.83.03.90. E-mail:
didier.raoult{at}medecine.univ-mrs.fr.


REFERENCES
1 - Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.[Abstract/Free Full Text]
2 - Felsenstein, J. 1989. PHYLIPphylogeny inference package. Cladistics 5:164-166.
3 - Lawson, P. A., E. Falsen, E. Akervall, P. Vandamme, and M. D. Collins. 1997. Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum schaalii comb. nov. and description of Actinobaculum schaalii sp. nov. Int. J. Syst. Bacteriol. 47:899-903.[Abstract/Free Full Text]
4 - Ludwig, W., G. Kirchhof, M. Weizenzgger, and N. Weiss. 1992. Phylogenetic evidence for transfer of Eubacterium suis to the genus Actinomyces as Actinomyces suis comb. nov. Int. J. Syst. Bacteriol. 42:161-165.[Abstract/Free Full Text]
5 - Miller, L., and T. Berger. 1985. Bacterial identification by gas chromatography of whole cell fatty acid, p. 228-241. Hewlett-Packard Co., Palo Alto, Calif.
6 - Walker, R. L., and N. J. MacLachlan. 1989. Isolation of Eubacterium suis from sows with cystitis. J. Am. Vet. Med. Assoc. 195:1104-1107.[Medline]
7 - Wegienek, J., and C. A. Reddy. 1982. Nutritional and metabolic features of Eubacterium suis. J. Clin. Microbiol. 15:895-901.[Abstract/Free Full Text]
8 - Weisburg, W. G., S. M. Barns, D. A. Pelletier, and D. J. Lane. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697-703.[Abstract/Free Full Text]
9 - Yamini, B., and R. F. Slocombe. 1988. Porcine abortion caused by Actinomyces suis. Vet. Pathol. 25:323-324.[Medline]
Journal of Clinical Microbiology, November 2002, p. 3938-3941, Vol. 40, No. 11
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.11.3938-3941.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
(2006). List of new names and new combinations previously effectively, but not validly, published.. Int. J. Syst. Evol. Microbiol.
56: 2025-2027
[Abstract]
[Full Text]
-
Sturm, P. D. J., Van Eijk, J., Veltman, S., Meuleman, E., Schulin, T.
(2006). Urosepsis with Actinobaculum schaalii and Aerococcus urinae. J. Clin. Microbiol.
44: 652-654
[Abstract]
[Full Text]
-
Reinhard, M., Prag, J., Kemp, M., Andresen, K., Klemmensen, B., Hojlyng, N., Sorensen, S. H., Christensen, J. J.
(2005). Ten Cases of Actinobaculum schaalii Infection: Clinical Relevance, Bacterial Identification, and Antibiotic Susceptibility. J. Clin. Microbiol.
43: 5305-5308
[Abstract]
[Full Text]
-
Fendukly, F., Osterman, B.
(2005). Isolation of Actinobaculum schaalii and Actinobaculum urinale from a Patient with Chronic Renal Failure. J. Clin. Microbiol.
43: 3567-3569
[Abstract]
[Full Text]
-
Rovery, C., Greub, G., Lepidi, H., Casalta, J.-P., Habib, G., Collart, F., Raoult, D.
(2005). PCR Detection of Bacteria on Cardiac Valves of Patients with Treated Bacterial Endocarditis. J. Clin. Microbiol.
43: 163-167
[Abstract]
[Full Text]
-
Drancourt, M., Berger, P., Raoult, D.
(2004). Systematic 16S rRNA Gene Sequencing of Atypical Clinical Isolates Identified 27 New Bacterial Species Associated with Humans. J. Clin. Microbiol.
42: 2197-2202
[Abstract]
[Full Text]